Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Spalding T, LaPrade RF, Murray IR, Krych AJ, Engebretsen L(2024) Favorable Patient-Reported, Clinical, and Functional Outcomes 2 Years After ACL Repair and InternalBrace Augmentation Compared With ACL Reconstruction and Healthy Controls: Letter to the Editor Am J Sports Med, 52(8), NP15 DOI 10.1177/03635465241247750, PubMed 38946455
Bukten A, Stavseth MR(2024) Estimated effects of opioid agonist treatment in prison on all-cause mortality and overdose mortality in people released from prison in Norway: a prospective analysis of data from the Norwegian Prison Release Study (nPRIS) Lancet Public Health, 9(7), e421-e431 DOI 10.1016/S2468-2667(24)00098-7, PubMed 38942554
Ness HT, Folvik L, Sneve MH, Grydeland H, Vidal-Piñeiro D, Raud L, Geier OM, Walhovd KB, Fjell AM(2024) Recalled through this day but forgotten next week?-retrieval activity predicts durability of partly consolidated memories Cereb Cortex, 34(6) DOI 10.1093/cercor/bhae233, PubMed 38937077